Revenue Summary of Biogen Inc.

Biogen Inc.'s latest annual revenue in 2023 was 9.83 Billion USD , down -3.32% from previous year.
Biogen Inc.'s latest quarterly revenue in 2024 Q3 was 2.46 Billion USD , up 4.79% from previous quarter.
Biogen Inc. reported a annual revenue of 10.17 Billion USD in annual revenue 2022, down -7.36% from previous year.
Biogen Inc. reported a annual revenue of 10.98 Billion USD in annual revenue 2021, down -18.32% from previous year.
Biogen Inc. reported a quarterly revenue of 2.35 Billion USD for 2024 Q2, up 6.94% from previous quarter.
Biogen Inc. reported a quarterly revenue of 2.2 Billion USD for 2024 Q1, down -7.79% from previous quarter.

Annual Revenue Chart of Biogen Inc. (2023 - 1989)

Historical Annual Revenue of Biogen Inc. (2023 - 1989)

Year	Revenue	Revenue Growth
2023	9.83 Billion USD	-3.32%
2022	10.17 Billion USD	-7.36%
2021	10.98 Billion USD	-18.32%
2020	13.44 Billion USD	-6.49%
2019	14.37 Billion USD	6.88%
2018	13.45 Billion USD	9.61%
2017	12.27 Billion USD	7.21%
2016	11.44 Billion USD	6.36%
2015	10.76 Billion USD	10.93%
2014	9.7 Billion USD	39.97%
2013	6.93 Billion USD	25.66%
2012	5.51 Billion USD	9.27%
2011	5.04 Billion USD	7.04%
2010	4.71 Billion USD	7.75%
2009	4.37 Billion USD	6.83%
2008	4.09 Billion USD	29.19%
2007	3.17 Billion USD	69.41%
2006	1.87 Billion USD	9.25%
2005	1.71 Billion USD	7.38%
2004	1.59 Billion USD	134.96%
2003	679.18 Million USD	-40.86%
2002	1.14 Billion USD	10.06%
2001	1.04 Billion USD	12.62%
2000	926.45 Million USD	16.62%
1999	794.43 Million USD	42.48%
1998	557.58 Million USD	28.46%
1997	434.04 Million USD	56.64%
1996	277.09 Million USD	82.67%
1995	151.69 Million USD	-2.98%
1994	156.34 Million USD	14.62%
1993	136.4 Million USD	10.27%
1992	123.7 Million USD	101.47%
1991	61.4 Million USD	22.55%
1990	50.1 Million USD	75.79%
1989	28.5 Million USD	38.35%

Year	Revenue	Revenue Growth
2024 Q3	2.46 Billion USD	4.79%
2024 Q2	2.35 Billion USD	6.94%
2024 Q1	2.2 Billion USD	-7.79%
2023 Q1	2.46 Billion USD	-3.18%
2023 Q3	2.53 Billion USD	3.03%
2023 FY	9.83 Billion USD	-3.32%
2023 Q2	2.45 Billion USD	-0.28%
2023 Q4	2.38 Billion USD	-5.69%
2022 Q4	2.54 Billion USD	1.42%
2022 Q3	2.5 Billion USD	-3.11%
2022 Q1	2.53 Billion USD	-7.39%
2022 FY	10.17 Billion USD	-7.36%
2022 Q2	2.58 Billion USD	2.26%
2021 FY	10.98 Billion USD	-18.32%
2021 Q3	2.77 Billion USD	0.14%
2021 Q4	2.73 Billion USD	-1.62%
2021 Q2	2.77 Billion USD	3.01%
2021 Q1	2.69 Billion USD	-5.56%
2020 Q3	3.37 Billion USD	-8.3%
2020 Q1	3.53 Billion USD	-3.73%
2020 Q2	3.68 Billion USD	4.17%
2020 FY	13.44 Billion USD	-6.49%
2020 Q4	2.85 Billion USD	-15.51%
2019 Q2	3.61 Billion USD	3.64%
2019 Q1	3.48 Billion USD	-1.04%
2019 Q4	3.67 Billion USD	1.98%
2019 FY	14.37 Billion USD	6.88%
2019 Q3	3.6 Billion USD	-0.46%
2018 FY	13.45 Billion USD	9.61%
2018 Q4	3.52 Billion USD	2.54%
2018 Q3	3.43 Billion USD	2.46%
2018 Q2	3.35 Billion USD	7.2%
2018 Q1	3.13 Billion USD	-5.32%
2017 FY	12.27 Billion USD	7.21%
2017 Q4	3.3 Billion USD	7.45%
2017 Q3	3.07 Billion USD	-0.02%
2017 Q2	3.07 Billion USD	9.52%
2017 Q1	2.81 Billion USD	-2.13%
2016 Q4	2.87 Billion USD	-2.84%
2016 FY	11.44 Billion USD	6.36%
2016 Q3	2.95 Billion USD	2.13%
2016 Q2	2.89 Billion USD	6.14%
2016 Q1	2.72 Billion USD	-3.96%
2015 Q2	2.59 Billion USD	1.44%
2015 Q4	2.83 Billion USD	2.21%
2015 Q3	2.77 Billion USD	7.19%
2015 FY	10.76 Billion USD	10.93%
2015 Q1	2.55 Billion USD	-3.25%
2014 Q2	2.42 Billion USD	13.7%
2014 FY	9.7 Billion USD	39.97%
2014 Q4	2.64 Billion USD	5.15%
2014 Q3	2.51 Billion USD	3.72%
2014 Q1	2.12 Billion USD	8.34%
2013 Q3	1.82 Billion USD	6.05%
2013 Q2	1.72 Billion USD	21.79%
2013 Q1	1.41 Billion USD	-0.2%
2013 FY	6.93 Billion USD	25.66%
2013 Q4	1.96 Billion USD	7.55%
2012 FY	5.51 Billion USD	9.27%
2012 Q4	1.41 Billion USD	29.17%
2012 Q3	1.09 Billion USD	-22.74%
2012 Q2	1.42 Billion USD	9.98%
2012 Q1	1.29 Billion USD	-2.62%
2011 Q3	1.3 Billion USD	8.38%
2011 Q4	1.32 Billion USD	1.28%
2011 FY	5.04 Billion USD	7.04%
2011 Q2	1.2 Billion USD	0.44%
2011 Q1	1.2 Billion USD	-1.29%
2010 Q1	1.1 Billion USD	-1.61%
2010 FY	4.71 Billion USD	7.75%
2010 Q2	1.21 Billion USD	9.36%
2010 Q3	1.17 Billion USD	-3.04%
2010 Q4	1.21 Billion USD	3.68%
2009 FY	4.37 Billion USD	6.83%
2009 Q4	1.12 Billion USD	0.58%
2009 Q3	1.12 Billion USD	2.49%
2009 Q2	1.09 Billion USD	5.48%
2009 Q1	1.03 Billion USD	-3.03%
2008 Q1	942.18 Million USD	5.47%
2008 Q4	1.06 Billion USD	-2.2%
2008 FY	4.09 Billion USD	29.19%
2008 Q3	1.09 Billion USD	10.02%
2008 Q2	993.44 Million USD	5.44%
2007 Q1	715.91 Million USD	798.29%
2007 Q4	893.3 Million USD	13.19%
2007 FY	3.17 Billion USD	69.41%
2007 Q2	773.17 Million USD	8.0%
2007 Q3	789.23 Million USD	2.08%
2006 Q3	703.49 Million USD	6.58%
2006 FY	1.87 Billion USD	9.25%
2006 Q1	611.17 Million USD	903.88%
2006 Q2	660.04 Million USD	8.0%
2006 Q4	-102.52 Million USD	-114.57%
2005 FY	1.71 Billion USD	7.38%
2005 Q2	605.63 Million USD	3.03%
2005 Q1	587.8 Million USD	2202.07%
2005 Q4	-76.02 Million USD	-112.75%
2005 Q3	596.21 Million USD	-1.56%
2004 Q4	-27.96 Million USD	-105.15%
2004 FY	1.59 Billion USD	134.96%
2004 Q3	543.27 Million USD	0.84%
2004 Q2	538.76 Million USD	-0.55%
2004 Q1	541.74 Million USD	275.35%
2003 Q2	325.64 Million USD	1.54%
2003 Q1	320.69 Million USD	6.04%
2003 FY	679.18 Million USD	-40.86%
2003 Q4	-308.94 Million USD	-190.39%
2003 Q3	341.78 Million USD	4.96%
2002 FY	1.14 Billion USD	10.06%
2002 Q1	288.34 Million USD	2.81%
2002 Q2	269.26 Million USD	-6.62%
2002 Q3	288.32 Million USD	7.08%
2002 Q4	302.43 Million USD	4.89%
2001 Q3	265.19 Million USD	1.74%
2001 Q1	237.04 Million USD	-3.38%
2001 Q4	280.45 Million USD	5.76%
2001 Q2	260.66 Million USD	9.96%
2001 FY	1.04 Billion USD	12.62%
2000 FY	926.45 Million USD	16.62%
2000 Q2	230.51 Million USD	6.3%
2000 Q3	233.75 Million USD	1.41%
2000 Q1	216.84 Million USD	-3.77%
2000 Q4	245.33 Million USD	4.95%
1999 FY	794.43 Million USD	42.48%
1999 Q3	208.4 Million USD	10.32%
1999 Q4	225.33 Million USD	8.13%
1999 Q2	188.9 Million USD	10.02%
1999 Q1	171.7 Million USD	1.97%
1998 Q3	145.9 Million USD	13.28%
1998 FY	557.58 Million USD	28.46%
1998 Q1	114.5 Million USD	-21.65%
1998 Q2	128.8 Million USD	12.49%
1998 Q4	168.38 Million USD	15.41%
1997 FY	434.04 Million USD	56.64%
1997 Q1	94.8 Million USD	-9.53%
1997 Q2	92.4 Million USD	-2.53%
1997 Q3	100.6 Million USD	8.87%
1997 Q4	146.14 Million USD	45.27%
1996 FY	277.09 Million USD	82.67%
1996 Q2	41.2 Million USD	19.77%
1996 Q3	96.8 Million USD	134.95%
1996 Q4	104.79 Million USD	8.25%
1996 Q1	34.4 Million USD	-35.21%
1995 Q3	33.9 Million USD	3.67%
1995 Q1	32 Million USD	-25.48%
1995 FY	151.69 Million USD	-2.98%
1995 Q4	53.09 Million USD	56.61%
1995 Q2	32.7 Million USD	2.19%
1994 Q3	31.8 Million USD	-3.05%
1994 Q2	32.8 Million USD	-20.39%
1994 Q1	41.2 Million USD	17.05%
1994 FY	156.34 Million USD	14.62%
1994 Q4	42.94 Million USD	35.04%
1993 FY	136.4 Million USD	10.27%
1993 Q2	34.7 Million USD	6.77%
1993 Q4	35.2 Million USD	3.83%
1993 Q3	33.9 Million USD	-2.31%
1993 Q1	32.5 Million USD	-36.89%
1992 Q4	51.5 Million USD	35.88%
1992 FY	123.7 Million USD	101.47%
1992 Q1	16.1 Million USD	4.55%
1992 Q2	18.1 Million USD	12.42%
1992 Q3	37.9 Million USD	109.39%
1991 Q4	15.4 Million USD	4.05%
1991 Q2	15.3 Million USD	-3.77%
1991 Q1	15.9 Million USD	15.22%
1991 FY	61.4 Million USD	22.55%
1991 Q3	14.8 Million USD	-3.27%
1990 Q2	12 Million USD	1.69%
1990 Q4	13.8 Million USD	10.4%
1990 FY	50.1 Million USD	75.79%
1990 Q1	11.8 Million USD	57.33%
1990 Q3	12.5 Million USD	4.17%
1989 FY	28.5 Million USD	38.35%
1989 Q3	7 Million USD	1.45%
1989 Q2	6.9 Million USD	-14.81%
1989 Q4	7.5 Million USD	7.14%
1989 Q1	8.1 Million USD	44.64%

Peer Revenue Comparison of Biogen Inc.

Name	Revenue	Revenue Difference
Amgen Inc.	28.19 Billion USD	65.11%
AstraZeneca PLC	45.81 Billion USD	78.53%
Gilead Sciences, Inc.	27.11 Billion USD	63.728%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	46.74 Million USD	-20941.867%
Scilex Holding Company	46.74 Million USD	-20941.867%

Global Stocks Search

Biogen Inc. (BIIB)

Revenue Summary of Biogen Inc.

Annual Revenue Chart of Biogen Inc. (2023 - 1989)

Historical Annual Revenue of Biogen Inc. (2023 - 1989)

Peer Revenue Comparison of Biogen Inc.